SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-024518
Filing Date
2020-02-05
Accepted
2020-02-04 21:48:02
Documents
5
Period of Report
2020-02-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d883170d8k.htm 8-K 23010
2 EX-99.1 d883170dex991.htm EX-99.1 6631
3 EX-99.2 d883170dex992.htm EX-99.2 29525
4 GRAPHIC g883170g0205022234758.jpg GRAPHIC 8181
5 GRAPHIC g883170g0205022605140.jpg GRAPHIC 36307
  Complete submission text file 0001193125-20-024518.txt   122046
Mailing Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129
Business Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129 617-259-1970
ZIOPHARM ONCOLOGY INC (Filer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33038 | Film No.: 20576219
SIC: 2834 Pharmaceutical Preparations